Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

The American Journal of Medicine
W Y ChanF Fuchs

Abstract

Prostaglandin synthetase inhibitors have been used in clinical trials for the treatment of primary dysmenorrhea on the theory that the disorder may be caused by a high level of prostaglandins. However, a causal role of prostaglandin in dysmenorrhea has not been established, and there is only indirect evidence that the amelioration of dysmenorrhea by prostaglandin synthetase inhibitors is related to their inhibition of prostaglandin synthesis in the uterus. We, therefore, monitored menstrual prostaglandin release in 14 dysmenorrheic patients in a controlled, double-blind, cross-over trial of ibuprofen (Motrin) and in two dysmenorrheic subjects while they were receiving oral contraceptive therapy and while they were not. A total of 89 menstrual cycles were studied. We found that ibuprofen therapy reduced menstrual prostaglandin release and relieved dysmenorrhea but that placebo therapy did not. Oral contraceptives decreased menstrual flow, reduced prostaglandin release and also alleviated dysmenorrhea. We conclude that primary dysmenorrhea is related to a high level of menstrual prostaglandin release. Ibuprofen inhibits prostaglandin synthesis whereas oral contraceptives inhibit ovulation and cyclic endometrial development. Thus,...Continue Reading

References

Apr 1, 1978·American Journal of Obstetrics and Gynecology·O Ylikorkala, M Y Dawood
Feb 18, 1978·Lancet·A B AndersonA C Turnbull
Apr 15, 1977·American Journal of Obstetrics and Gynecology·M R HenzlS Bessler
Oct 1, 1979·Prostaglandins·A KauppilaO Ylikorkala
May 1, 1976·Prostaglandins·V LundströmN Wiqvist
Apr 1, 1975·American Journal of Obstetrics and Gynecology·E J SinghF P Zuspan
Aug 30, 1975·The Medical Journal of Australia·H M Carey
Apr 1, 1965·The Journal of Obstetrics and Gynaecology of the British Commonwealth·V R PICKLESG N SMITH
Jan 1, 1974·The Journal of Physiology·J DownieM Wunderlich

❮ Previous
Next ❯

Citations

Aug 1, 1987·The Australian & New Zealand Journal of Obstetrics & Gynaecology·I S Fraser, G McCarron
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Chooi L WongMichelle Proctor
Sep 6, 2014·Cancer Causes & Control : CCC·Ana BabicKathryn L Terry
Jul 6, 2018·The Journal of Obstetrics and Gynaecology Research·Nazish Rafique, Mona H Al-Sheikh
Jun 1, 1982·Journal of Human Stress·N F WoodsA Most
Jun 13, 1998·Medicine and Science in Sports and Exercise·L M GolombM P Warren
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·W Y Zhang, A Li Wan Po
Jun 10, 2008·Journal of Women's Health·Lisa K Mannix
Jul 2, 2015·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Omid R ZekavatFarzaneh Alipour
Sep 24, 2015·Current Medical Research and Opinion·Brian A Hauck, Vivien Brown
Sep 1, 1988·British Journal of Obstetrics and Gynaecology·M Rees
Jan 1, 1989·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·C Benedetto
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·R P Evens
Jul 1, 1981·Pharmacotherapy·R R Miller
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·N J Wenzloff, L Shimp
Feb 26, 1999·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·D Serfaty, M L Vree
Aug 2, 2006·Obstetrics and Gynecology·M Yusoff Dawood
Aug 8, 2002·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Diana TaylorJoel Kohn
Sep 9, 2015·Human Reproduction Update·Stella IacovidesFiona C Baker
Jul 26, 2014·European Journal of Pain : EJP·C X ChenS E Ward
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jane MarjoribanksMichelle Proctor
Mar 1, 1986·The Physician and Sportsmedicine·J Brooks-GunnM P Warren
Apr 28, 2017·Nature Communications·Zhiqiang LiYongyong Shi
Oct 13, 2018·Acta Obstetricia Et Gynecologica Scandinavica·Lisa SödermanLena Marions
May 20, 1988·The American Journal of Medicine·M Y Dawood
Aug 3, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Xuemei LiSha Yang
Feb 1, 1996·The Journal of the American Association of Gynecologic Laparoscopists·A J DulebaD L Olive

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Medicine
M Yusoff Dawood
The Journal of Reproductive Medicine
S L Corson, R J Bolognese
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
O Lalos, B Nilsson
© 2021 Meta ULC. All rights reserved